Product Overview
The document describes the Duplex Real-Time PCR Diagnostic Kit designed for the rapid detection of Influenza Virus A and B. This kit is produced by Beijing Applied Biological Technologies Co., Ltd. and is registered under NMPA 20193400251.
Clinical Significance
Influenza is a highly contagious respiratory infection caused by influenza viruses, primarily transmitted through droplets. The kit aids in distinguishing influenza from other cold types using nucleic acid testing, which is crucial for accurate diagnosis and treatment. The test helps prevent the misuse of neuraminidase inhibitors, reducing antibiotic resistance risks.
Product Features- Detects both Influenza A and B viruses.
- Designed to avoid mutations in the conserved regions of the viruses, ensuring reliable detection.
- High sensitivity with a detection limit as low as 1000 PFU/ml.
- Validated by over 400 CDCs in China with more than 1 million tests conducted.
- Includes internal standard monitoring to prevent false negatives.
- Internal control allows for multiple freeze-thaw cycles without affecting results.
Significance of Test Results- Negative Result: Excludes influenza infection, preventing unnecessary use of antivirals.
- Positive Result: Enables accurate treatment, reduces severe illness risk, and helps control nosocomial infections. It also supports early detection and treatment, reducing hospitalization time and healthcare costs.
Contact InformationAddress: B-1st, Zhengdan International Building, No.33 Kexueyuan Road, Changping District, Beijing 102206, China
Tel: +86-10-80727800
Website:
http://www.x-abt.comEmail:
[email protected] See more